Estrogen Therapy In Transgender Women May Put Them At Higher Risk For Cardiac Events

reports that a review suggests “the use of estrogen therapy in transgender women appears to put them at increased risk for cardiac events.” This “analysis found a ‘definite’ increase in venous thromboembolism (VTE) and ‘probable’ increases in both the risk of myocardial infarction (MI) and stroke among transgender women (those born biologically male but identifying as female), according to” the researchers. Meanwhile, “among transgender men (those born as female but identifying as male), there appeared to be no increase in stroke or VTE, while the risk of MI is still unknown.” The findings were published in Reviews in Endocrine and Metabolic Disorders. https://www.medpagetoday.com/cardiology/venousthrombosis/74425